episode 8 - long-term effects of disease-modifying therapies
Published 10 years ago • 211 plays • Length 8:21Download video MP4
Download video MP3
Similar videos
-
36:25
considerations for the selection of disease-modifying treatments in sma: a case-based discussion
-
36:25
considerations for the selection of disease-modifying treatments in sma: a case-based discussion
-
0:16
treatment sequencing in multiple sclerosis: the benefits of disease-modifying therapies
-
14:49
“choosing the right disease-modifying therapy,” geeta ganesh, m.d.
-
1:05:12
disease modifying therapies in multiple sclerosis
-
59:42
new drug therapies – professor perry elliott, hosted by libby jarman
-
5:03
disease progression in multiple sclerosis
-
28:37
2022 rnds | what are the long-term treatments for nmosd and mogad?
-
41:11
wellbeing wednesdays: episode 8 - "alcohol use disorder: our nation's hidden epidemic"
-
6:42
optimizing the use of disease modifying therapy in multiple sclerosis
-
30:59
disease modifying therapies: clinical trial readiness in dravet syndrome
-
1:23:16
disease modifying therapies
-
7:00
5/10 biomarkers and disease-modifying treatments in multiple sclerosis | professor gavin giovannoni
-
16:46
nmosd: disease modifying therapies [2024 update]
-
45:02
clinical implications of late-breaking data on disease modifying therapies for ms management
-
33:10
what's new about disease modifying therapies and mri's - multiple sclerosis
-
4:24
cost of disease-modifying therapy in multiple sclerosis
-
31:37
highly effective disease-modifying therapies for multiple sclerosis
-
5:21
what to expect from disease modifying therapies for multiple sclerosis
-
58:54
disease-modifying and symptomatic therapies in the pipeline - updates in pd
-
27:05
preserving brain/cognitive reserve in ms patients: role of disease modifying therapies
-
3:38
dr john corboy: why disease-modifying therapy efficacy varies with age